Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $27.98 million as of May 1, 2024. Its market cap has decreased by -29.52% in one year.

Market Cap

27.98M

Enterprise Value

27.74M

1-Year Change

-29.52%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, Nymox Pharmaceutical's market cap has decreased from $106.00M to $27.98M, a decrease of -73.60%. That is a compound annual growth rate of -5.27%.

Market Cap History

Date	Market Cap	% Change
Jul 6, 2023	18.10M	-19.56%
Jul 5, 2023	22.50M	-5.06%
Jul 3, 2023	23.70M	37.79%
Jun 30, 2023	17.20M	-11.79%
Jun 29, 2023	19.50M	-23.53%
Jun 28, 2023	25.50M	-9.25%
Jun 27, 2023	28.10M	-6.64%
Jun 26, 2023	30.10M	4.15%
Jun 23, 2023	28.90M	-8.83%
Jun 22, 2023	31.70M	-7.85%
Jun 21, 2023	34.40M	0.29%
Jun 20, 2023	34.30M	0.88%
Jun 16, 2023	34.00M	-2.58%
Jun 15, 2023	34.90M	2.05%
Jun 14, 2023	34.20M	1.18%
Jun 13, 2023	33.80M	-3.70%
Jun 12, 2023	35.10M	-0.57%
Jun 9, 2023	35.30M	-2.22%
Jun 8, 2023	36.10M	-1.63%
Jun 7, 2023	36.70M	-0.54%
Jun 6, 2023	36.90M	3.07%
Jun 5, 2023	35.80M	-5.29%
Jun 2, 2023	37.80M	-0.53%
Jun 1, 2023	38.00M	-
May 31, 2023	38.00M	-6.63%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	742.64B
Novo Nordisk	569.83B
UnitedHealth Group	445.04B
Johnson & Johnson	348.43B
Merck & Co.	327.27B
AbbVie	287.98B
AstraZeneca	235.22B
Thermo Fisher	217.09B

Market Cap Rankings